Omalizumab for chronic urticaria.

  title={Omalizumab for chronic urticaria.},
  author={Marcus Maurer and Karin E. Rosen and Hsin-ju Hsieh},
  journal={The New England journal of medicine},
  volume={368 26},
The Authors Reply: We agree with Little et al. that clinicians should be aware of the risk of cardiovascular morbidity and limit the dose to the heart when performing radiotherapy for breast cancer. As pointed out by Liu et al., many radiotherapy centers already do this by means of techniques such as breath hold, by treating patients in the prone position (as indicated by Formenti et al.), or by intraoperative radiotherapy (as indicated by Vaidya et al.). We agree with Liu et al. that a… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 8 times over the past 90 days. VIEW TWEETS


Publications referenced by this paper.
Showing 1-10 of 14 references

Physical urticaria. Curr Allergy Asthma Rep 2012;12:281-7

  • M Abajian, A Młynek, M. Maurer
  • DOI: 10.1056/NEJMc1305687 The New England Journal…
  • 2014

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase

  • M Abajian, A Młynek, M Maurer
  • J Allergy Clin Immunol
  • 2011

Similar Papers

Loading similar papers…